Quantinno Capital Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.75M Buy
205,820
+50,784
+33% +$1.01M ﹤0.01% 1676
2026
Q2
$3.5M Buy
155,036
+87,336
+129% +$2.19M ﹤0.01% 1523
2026
Q1
$1.69M Buy
+67,700
New +$1.91M ﹤0.01% 1737

Other funds holding PRCT

Quantinno Capital Management's PRCT Position: Q3 2026 in Review

Quantinno Capital Management increased its Procept Biorobotics (PRCT) stake by 33% in Q3 2026, buying an estimated $1.01M and bringing the position to 205,820 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1676.

Quantinno Capital Management first reported a position in PRCT in Q1 2026 and has held it in 3 quarters since. 232 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Quantinno Capital Management held 205,820 shares of Procept Biorobotics worth $3.75M as of Q3 2026.
  • Quantinno Capital Management bought 50,784 Procept Biorobotics shares in Q3 2026, an estimated $1.01M.
  • Procept Biorobotics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1676 holding.
  • Quantinno Capital Management first reported a position in Procept Biorobotics in Q1 2026 and has held it in 3 quarters since.
  • 232 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.